Abbott ACT I debut
This article was originally published in The Gray Sheet
Executive Summary
First patient is enrolled in firm's 50-site, 1,500 patient Asymptomatic Subjects with Significant Extracranial Carotid Occlusive Disease Trial (ACT I), Abbott announces March 31. The randomized clinical trial will compare carotid stenting to endarterectomy surgery in asymptomatic, surgery-eligible patients in support of a PMA for Mednova's self-expanding nitinol Xact carotid stent and Emboshield embolic protection device (1"The Gray Sheet" Jan. 24, 2005, p. 3)...